2,354 material Form 8-K filings that 2,004 companies we cover made with the SEC in November 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 1,081 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On November 5, 2026, Our Bond, Inc. and Ascent Partners Fund LLC amended their Securities Purchase Agreement dated November 3, 2026. The amendment modifies certain covenant restrictions on the company's subsequent equity sales. The 8-K does not state the specific changes or any dollar amounts, so the effect on shareholders is not quantified in the filing.
Amendment dated November 5, 2026, to the Securities Purchase Agreement dated November 3, 2026, with Ascent Partners Fund LLC
Modifies covenant restrictions on the company's subsequent equity sales
Amendment filed as Exhibit 10.1; the 8-K does not give specific terms or figures
LASE Corp. said its Board appointed Sanjay Adhav and Chief Financial Officer Timothy A. Peterman as directors, effective November 3, 2026, to fill two existing vacancies. The company announced the appointments in a press release dated November 9, 2026, and the filing discloses no related-party transactions or arrangements for either appointee.
Board appointed Sanjay Adhav and CFO Timothy A. Peterman as directors, effective November 3, 2026, filling two existing vacancies
Adhav has served as President of Quantum Technology, Inc. since 2013; Peterman was CEO of iMedia Brands, Inc. from 2019 to 2023
Press release announcing the appointments was issued November 9, 2026 (Exhibit 99.1)
TechPrecision and its subsidiaries Ranor and Stadco entered a $10.0 million credit agreement with Rosenthal & Rosenthal on November 3, 2026, and used the proceeds to repay the prior Beacon Bank & Trust loan agreement. The facility includes a revolving line of up to $5.0 million and two term loans, and it requires a minimum quarterly tangible net worth of $5.5 million. The company also said it may be unable to file its Form 10-Q for the period ended September 30, 2026 on time.
Facility includes a $5.0 million revolving line, a $1.5 million three-year term loan and a $3.5 million five-year term loan, secured by substantially all personal property and a first mortgage on Ranor's Westminster, Massachusetts facility
Prior Beacon Bank & Trust loan agreement was terminated and repaid in full on November 3, 2026; closing costs were approximately $0.6 million.
Company issued 25,000 shares of common stock to the broker that introduced the lender.
Management expects the financing to alleviate the substantial doubt about going concern; tangible net worth was $7.6 million as of June 30, 2026 against the $5.5 million covenant.
Reliance Global Group, Inc. (EZRA) closed its acquisition of the Oblivus GPU cloud computing platform on November 3, 2026, paying $3,000,000 in cash at closing from cash on hand, with up to $750,000 more in milestone payments that depend on future revenue. The company says Oblivus generated about $1.5 million in revenue for the twelve months ended September 2026, based on unaudited seller records, and that the deal marks its entry into the AI infrastructure market. Shareholders should note that the company has not yet filed the required acquired-business financial statements and pro forma information, and that its trading symbol is set to change to XGPU on November 10, 2026.
Closing payment of $3,000,000 in cash; up to two $375,000 milestone payments tied to average monthly cash revenue of $79,000 and $120,000
Oblivus reported about $1.5 million in revenue for the twelve months ended September 2026, per seller's unaudited records
Consulting agreement with founder Matthew Antoun: $250,000 in cash fees over 12 months, plus stock up to $600,000 subject to Board approval
Trading symbol expected to change from EZRA to XGPU on Nasdaq at the open on November 10, 2026
On November 6, 2026, U.S. GoldMining agreed to sell 408,163 common shares at $4.90 each to an institutional investor in a registered direct offering. Gross proceeds are expected to be about $2.0 million before offering expenses, with closing expected on or about November 9, 2026. The company plans to use the net proceeds for working capital and general corporate purposes.
Shares offered: 408,163 common shares at $4.90 per share
Expected gross proceeds: approximately $1,999,998.70 before offering expenses
Offering made under an effective Form S-3 shelf registration (File No. 333-279435) and a prospectus supplement dated November 6, 2026
Expected closing on or about November 9, 2026, subject to customary conditions
At its November 9, 2026 annual meeting, Lisata Therapeutics stockholders approved the 2026 Equity Incentive Plan, the 2026 Employee Stock Purchase Plan, and a reverse stock split authorization with a ratio between 1-for-5 and 1-for-15. The vote on the Series C preferred stock conversion proposal, which would exceed 20% of outstanding common stock and result in a change of control, was not held and the meeting was adjourned. The conversion vote will resume at a reconvened meeting on November 30, 2026.
2026 Equity Incentive Plan approved with an initial reserve of 44,764,472 shares; 2,924,154 votes for and 1,552,345 against.
2026 Employee Stock Purchase Plan approved with an initial reserve of 3,730,372 shares.
Reverse stock split proposal approved with a ratio to be set by the Board between 1-for-5 and 1-for-15; 7,524,706 votes for.
Series C preferred conversion proposal not voted; reconvened meeting set for November 30, 2026 at 11:00 a.m. Eastern.
QVC Group said it will file its third-quarter fiscal 2026 results on Form 10-Q with the SEC on Monday, November 16, 2026. The company will also post an audio review of the results on its investor relations website, led by Interim CEO and Chairman Mike George and CFO Bill Wafford. The announcement gives shareholders the filing date and review format but no financial figures.
Form 10-Q for the quarter ended September 30, 2026 to be filed Monday, November 16, 2026
Audio recording reviewing results to be posted to the investor relations website
Review to be led by Interim CEO and Chairman Mike George and CFO Bill Wafford
The 8-K and press release were furnished under Regulation FD and are not deemed filed
DoubleVerify said it expects the merger under its August 6, 2026 agreement to close in the fourth quarter of 2026, subject to remaining closing conditions. Under the merger, DoubleVerify will survive as a wholly owned subsidiary of Neptune BidCo US Inc., so shareholders will be affected by the completion timing and terms of the deal.
Merger Agreement dated August 6, 2026, with Neptune BidCo US Inc. (Parent) and Wallace Merger Sub Inc. (Merger Sub)
Company expects closing during the fourth quarter of 2026, subject to satisfaction or waiver of remaining conditions
After the merger, DoubleVerify continues as the surviving corporation and a wholly owned subsidiary of Parent
Filing is made under Regulation FD and restates terms of a previously announced transaction
UWM Holdings Corporation announced the final subscription price for its rights offering of up to 200,000,000 Class A common shares: $2.00 per share. The price is the greater of $2.00 and 85% of the 10-day volume-weighted average NYSE sales price ending November 9, 2026, so the $2.00 floor applied. Subscription rights expire at 5:00 p.m. Eastern Time on November 12, 2026, unless extended.
Final subscription price is $2.00 per share, the greater of $2.00 and 85% of the 10-day volume-weighted average price ending November 9, 2026.
The rights offering covers up to 200,000,000 shares of Class A common stock.
Subscription rights expire at 5:00 p.m. Eastern Time on November 12, 2026, unless extended.
Exercised rights can be withdrawn until 5:00 p.m. Eastern Time on November 10, 2026, unless the offering is extended; the company may amend, withdraw or terminate the offering with consent of the Backstop Purchasers.
JBS N.V. agreed to acquire Flora Produtos de Higiene e Limpeza S.A., a Brazilian personal care and household products company, from its controlling shareholder J&F, in a transaction valued at US$542 million including assumed debt. JBS also agreed to buy Canal Rural, a Brazilian agribusiness media company, for R$88.1 million, and both deals are related-party transactions to be paid mainly in JBS Class A shares, which would add to the share count and dilute existing holders.
Flora: R$2.968 billion purchase price (US$542 million enterprise value); equity consideration of US$367 million to be paid in JBS Class A shares and/or BDRs
Canal Rural: R$88.1 million purchase price, paid to J&F in Class A shares; the Ex-99.1 release gives a US$11 million transaction value
Share issuance is based on a reference price of R$66.82916 per share (US$12.20 30-day volume-weighted average), with about 31.4 million treasury shares, or 2.9% of the share count, cited in the market presentation
Both agreements were signed November 9, 2026, and the transactions are expected to close in December 2026, subject to customary closing conditions
AGNT, Inc. entered into a Termination and Release Agreement with founder Glenn Sanford, effective retroactively to October 8, 2026, the date his employment ended in connection with the previously announced CEO transition. Sanford remains Chairman of the Board, and the agreement does not govern his board service. The release of claims is not yet effective, and the filing does not provide financial figures for the payments.
Separation Date is October 8, 2026; agreement signed November 9, 2026, and the release has not yet become effective.
Sanford keeps eligibility for eXp Realty revenue share at the highest front line qualifying agent tier, for as long as he holds Vested Status.
Company will pay or reimburse COBRA continuation coverage until the first anniversary of the Separation Date, subject to the release becoming effective.
A previously anticipated consulting agreement was not entered into; Sanford has no obligation to provide services.
Effective November 1, 2026, Matthew DiCanio became President and Chief Executive Officer, William K. Newton moved to Executive Chairman, and Tanner Newton became Executive Vice President and Chief Financial Officer. The filing also details new employment agreements and restricted stock grants to named executive officers, which set severance and change-in-control terms for shareholders to weigh.
Matthew DiCanio: President and CEO, base salary $785,000, target bonus 125% of base salary
William K. Newton: Executive Chairman, base salary $550,000, target bonus 85% of base salary
Tanner Newton: EVP and CFO, base salary $425,000, target bonus 75% of base salary
Restricted stock granted November 3, 2026 vests equally over four years; DiCanio received 164,894 shares
American Tower priced three registered senior unsecured note offerings totaling $1.5 billion on November 9, 2026. The notes are fungible with existing notes issued on September 14, 2026, and expected net proceeds are $1,474.9 million, which the company intends to use to repay borrowings under its $6.0 billion revolving credit facility and for general corporate purposes.
2031 notes: $450.0 million at a 5.300% interest rate, priced at 99.387% of face value
2033 notes: $500.0 million at a 5.560% interest rate, priced at 99.369% of face value
2036 notes: $550.0 million at a 5.750% interest rate, priced at 98.986% of face value
Expected net proceeds of $1,474.9 million, to repay revolver borrowings and for general corporate purposes
Energy Fuels Inc. said its board appointed Jeffrey Olsen as a director and as a member of the Audit Committee, effective immediately, on November 3, 2026. The filing describes his standard non-employee director compensation and a restricted stock unit grant, which is routine board refreshment that adds an independent voice to the audit oversight function.
Board appointed Jeffrey Olsen as director and Audit Committee member on November 3, 2026, effective immediately
Olsen received 2,078 restricted stock units granted November 3, 2026 at a grant price of $7.99 per underlying share
RSUs vest in three installments: 1,039 on January 27, 2027, 519 on January 27, 2028, and 520 on January 27, 2029
NIKE appointed Dan McKenzie as Vice President, Chief Accounting Officer, Finance Operations & Transformation, and principal accounting officer, effective November 9, 2026. As of the same date, CFO David Denton stops serving as Interim Corporate Controller and principal accounting officer. McKenzie retired from NIKE in July 2026 and returns under an offer letter dated November 4, 2026.
McKenzie's pay under the offer letter: $500,000 base salary, 50% target annual bonus, and a $525,000 annual long-term incentive target.
McKenzie will receive a $600,000 target-value sign-on RSU award that vests in three equal annual installments.
David Denton, Executive Vice President and CFO, ceases as Interim Corporate Controller and principal accounting officer effective November 9, 2026.
McKenzie previously served as VP, CFO, Global Operations and Technology from August 2025 to July 2026, and spent more than 19 years at NIKE.
Forge Nano Holdings said it completed its merger with HzO, Inc. on November 4, 2026, with HzO surviving as a wholly owned subsidiary. HzO stockholders were issued Forge Nano common stock as consideration, and part of that stock is held back for twelve months to secure post-closing adjustments and indemnification. The filing adds dilution from the new shares, but it does not provide HzO financial results or the effect on Forge Nano's earnings.
Merger consideration is based on a $55.0 million base purchase price, plus or minus closing cash, working capital, indebtedness and expense adjustments, divided by $10.00 per share.
Forge Nano issued 5,772,645 shares at the Effective Time, with 1,533,795 Holdback Shares held back for twelve months.
Shares received by HzO stockholders are locked up until the earlier of six months after the Effective Time or when the stock closes at or above $12.00 for 20 of 30 trading days.
HzO's CFO Jason Savod and President and COO Rachael Lerebours signed employment agreements with Forge Nano effective after the Effective Time.
Pangaea Logistics Solutions chair Richard T. du Moulin notified the Board on November 3, 2026, that he will retire as a director effective December 31, 2026. He has served on the Board since the company's 2014 IPO, and the filing says his affiliation with the company dates back more than 25 years. The filing does not name a successor.
Retirement notified to the Board on November 3, 2026, effective December 31, 2026
Du Moulin has served as a director since Pangaea's 2014 IPO and was affiliated with the company for more than 25 years
Claus Boggild, a founder and Lead Independent Director, praised his knowledge, forethought and integrity
Genuine Parts Company's Board declared a regular quarterly cash dividend of $1.0625 per share on November 9, 2026. The dividend is payable January 5, 2027 to shareholders of record on December 4, 2026. The filing is a routine dividend declaration and reports no earnings, guidance, or other financial results.
Regular quarterly cash dividend of $1.0625 per share declared November 9, 2026
Payable January 5, 2027 to shareholders of record on December 4, 2026
Press release furnished as Exhibit 99.1; no earnings or guidance included
UnitedHealth Group appointed Madeline Bell, former president and CEO of Children's Hospital of Philadelphia, as an independent director, effective November 3, 2026, as disclosed in a November 9, 2026 filing. The appointment is a board change with no financial figures attached, and Ms. Bell has not yet been assigned to any board committee.
Madeline Bell appointed independent director, effective November 3, 2026; no committee assignments yet
Bell retired as CHOP CEO last month, after joining CHOP as a pediatric staff nurse in 1983
Director compensation follows the company's standard non-employee director program; company will enter its standard indemnification agreement with her
GeoVax Labs appointed Tyler O'Brien as interim Chief Executive Officer and Chairman of the Board effective November 8, 2026, and added Shahin Behroyan as a director effective November 5, 2026. The filing follows the resignation of five former directors effective October 23, 2026, and it references a dispute over the termination of a former executive, Mr. Dodd, for Cause, which the company says could lead to severance or litigation. Shareholders face a leadership change at the top of the company while a permanent CEO is sought.
Tyler O'Brien appointed interim CEO and Chairman of the Board effective November 8, 2026; will serve until a permanent principal executive officer is appointed or designated
Shahin Behroyan appointed to the Board effective November 5, 2026, to fill a vacancy from the resignation of five former directors effective October 23, 2026
Behroyan is not yet on any committee; Board determined he is independent under Nasdaq Rule 5605(a)(2)
Forward-looking statements cite a possible dispute with Mr. Dodd over termination for Cause, with potential severance of three times base salary and target bonus
Vestis Corporation said its Vice President and Chief Accounting Officer, John Laveck, will resign effective December 11, 2026, to pursue an opportunity outside the company's industry. The company said the resignation is not due to any disagreement over operations, policies or practices, and a search for a replacement has begun.
John Laveck notified the company of his resignation on November 4, 2026, effective December 11, 2026.
Russell T. Tiejema, Executive Vice President and Chief Financial Officer, will act as principal accounting officer until a successor is appointed.
The filing states Mr. Tiejema will receive no additional compensation for the added role.
KBR said its lead independent director, Wendy Masiello, and director Nchacha Etta will retire from its board, and Executive Vice President Mark Sopp will retire from the company, all effective upon completion of the planned Trinzic spin-off. KBR also announced the expected Trinzic board, with Masiello as chair and Michael LaRouche as president and CEO-designate, and the spin-off is targeted for January 4, 2027, subject to final board approval.
Masiello (Lead Independent Director) and Etta (board member) notified KBR on November 5, 2026 of their retirements, effective upon completion of the spin-off
Sopp, Executive Vice President, Strategic Transactions, notified KBR on November 6, 2026 of his retirement and will receive no severance payments or benefits
KBR said the retirements were not the result of any disagreement with KBR on its operations, policies or practices
The spin-off is targeted for January 4, 2027, and Trinzic's board will have eight members, with Masiello as chair
Upstart's Chief Accounting Officer and Principal Accounting Officer, Natalia Mirgorodskaya, informed the company on November 3, 2026 that she will resign effective November 30, 2026, to pursue another opportunity. The company said the resignation does not stem from any disagreement over its operations, policies or practices, and CFO Andrea Blankmeyer will serve as Interim Principal Accounting Officer while a permanent replacement is sought.
Natalia Mirgorodskaya's resignation takes effect November 30, 2026; she informed the company on November 3, 2026.
The filing states the resignation is not due to any disagreement with the company on operations, policies or practices.
CFO Andrea Blankmeyer becomes Interim Principal Accounting Officer upon the resignation; her compensation is not being adjusted.
The company is conducting a search for a permanent replacement; no successor is named in the filing.
On November 9, 2026, Humana Inc. announced cash tender offers for eight series of its outstanding senior notes, with an aggregate purchase cap of $1.5 billion excluding accrued coupon payments. The offers expire at 5:00 p.m. New York City time on November 16, 2026, with settlement expected November 18, 2026. The filing is a debt management action and does not state its effect on earnings or guidance.
Aggregate purchase cap of $1.5 billion, excluding accrued coupon payments, subject to proration and acceptance priority levels
Series cap of $800 million on the 5.375% Senior Notes due 2031
Offers expire 5:00 p.m. New York City time on November 16, 2026; pricing is set on the same day at 3:00 p.m.
Expected settlement date is November 18, 2026; dealer managers include Barclays, BofA Securities, PNC and U.S. Bancorp
Hornbeck Offshore Services CEO Todd Hornbeck terminated a 10b5-1 trading plan he had adopted on September 1, 2026, which provided for the sale of 1,170,405 shares of common stock. The filing states that no shares were sold under the plan before it was terminated.
Terminated on November 9, 2026 by Todd Hornbeck, President, CEO and director
Plan adopted September 1, 2026 covered sale of 1,170,405 shares
No shares were sold under the plan before termination
Shares covered were awarded before the merger with Helix Energy Solutions Group, Inc. under Legacy Hornbeck's management incentive plan
On November 9, 2026, Equinix Europe 2 Financing Corporation, an indirect wholly-owned subsidiary, issued €2.5 billion of senior notes in four series, fully and unconditionally guaranteed by Equinix, Inc. The notes carry fixed coupons from 4.150% to 5.450% and mature between 2028 and 2038, and Equinix intends to allocate the proceeds to eligible green projects. For shareholders, this adds debt to the company's balance sheet, though the filing does not compare it with existing debt levels.
€650 million 4.150% notes due November 9, 2028, and €700 million 4.800% notes due February 15, 2033
€500 million 5.100% notes due November 9, 2035, and €650 million 5.450% notes due November 9, 2038
Net proceeds are intended for eligible green projects; pending allocation, they may be held in cash or used to repay existing borrowings
Equinix hedged part of the interest rate risk on the 2035 and 2038 notes, with effective all-in rates of 4.91% and 5.42%
AH Realty Trust founder Daniel Hoffler resigned from its board of directors, and the board appointed David Hirsh as an independent director to fill the vacancy. The 8-K says Hoffler's resignation was not due to any disagreement with the company, and the press release says both changes took effect November 6, 2026.
Daniel A. Hoffler, the company's founder, resigned from the board; the 8-K says he informed the board on November 5, 2026 and the resignation was effective immediately
The press release says Hoffler retired effective November 6, 2026
David Hirsh, age 63, was appointed an independent director and will serve until the 2027 annual meeting of stockholders
Hirsh has not been named to any board committees; he previously spent about 16 years at Blackstone Inc., retiring in January 2018
Cannae Holdings released its third quarter 2026 results on November 9, 2026, posting them on its website and in a shareholder letter, with a conference call scheduled for 5:00pm Eastern that day. The letter highlights a 70% drop in holding company expenses, $111 million of year-to-date share buybacks, and $793 million of proceeds from noncore asset sales since the start of 2025, though the excerpt does not state consolidated third quarter revenue, profit or per-share figures.
Holding company expenses fell $58.8 million, or 70%, in the first nine months of 2026 compared with 2025.
Year to date in 2026, Cannae repurchased 7.7 million shares for $111 million, representing 16.4% of shares outstanding, and paid $20 million in dividends.
Proceeds from noncore asset sales totaled $793 million from the beginning of 2025 through the third quarter of 2026.
Two directors will not stand for re-election at the December 11, 2026 annual meeting, and the board will shrink to ten members afterward.
FedEx Corp. elected Katherine M. Boyle, a general partner at Andreessen Horowitz, as a director effective November 9, 2026, and appointed her to the Governance, Safety, and Public Policy Committee and the Cyber and Technology Oversight Committee. The filing says the board now has 12 members, nine of whom are independent, and Boyle's term runs to the 2027 annual meeting. The change is administrative and does not alter FedEx's reported results or guidance.
Boyle was elected effective immediately on November 9, 2026, with a term expiring at the 2027 annual meeting of stockholders.
She joins the Governance, Safety, and Public Policy Committee and the Cyber and Technology Oversight Committee.
Board size is now 12 members, nine of whom are independent, per the press release.
Boyle will receive restricted stock units with a prorated target value of $98,900 and a prorated annual retainer of $64,400.
Stryker's board increased its size from 11 to 12 directors and elected James E. Davis, CEO and President of Quest Diagnostics, to fill the new seat. The election takes effect January 1, 2027, and Davis has not yet been assigned to any board committee.
Board expanded from 11 to 12 authorized directors on November 3, 2026
James E. Davis, CEO and President of Quest Diagnostics since November 2022, elected to fill the vacancy effective January 1, 2027
Davis will receive non-employee director compensation consistent with other directors and will sign the company's standard director indemnification agreement
No financial results or guidance were included in the filing
Immuneering's Board appointed Grant C. Bogle, MBA, as a Class III director on November 9, 2026. He will receive the standard non-employee director compensation and has signed the company's standard director and officer indemnification agreement, but has not yet been named to a Board committee.
Appointed to the Board as a Class III Director on November 9, 2026
Compensated under the company's non-employee director arrangements
No committee assignment at this time
No arrangement or understanding under which Bogle was elected, per the filing
Valor Energy entered an amendment to its equity transfer agreement with Glorious Star, LLC for the Youngstown Computing Center, changing how the $360,000 deposit is handled and setting a closing deadline. The filing states the remaining purchase price is payable at closing and that any additional power capacity would be a separate transaction requiring its own agreement, which does not affect the closing obligations.
Purchase price is $3,600,000; the $360,000 deposit is now paid directly to the seller after Valor confirms due diligence and its Initial Valuation are satisfactory, replacing escrow
Payment is a generally non-refundable down payment credited toward the price, subject to refund provisions in the amendment
Closing is due by the thirtieth Business Day after the original October 18, 2026 effective date, unless extended in writing
Amendment dated November 3, 2026; filed November 9, 2026 as Exhibit 10.1
Genworth Financial said its Vice President and Controller, Darren W. Woodell, resigned to pursue a new opportunity, and the board appointed Chief Financial Officer Jerome T. Upton as interim Principal Accounting Officer effective November 6, 2026. The filing also notes Upton will become President and Chief Executive Officer effective January 1, 2027, following the retirement of Thomas J. McInerney.
Darren W. Woodell resigned as Vice President and Controller; the company accepted the resignation on November 6, 2026.
Jerome T. Upton, currently Executive Vice President and Chief Financial Officer, serves as interim Principal Accounting Officer until a permanent appointment is made.
Upton's compensatory arrangements will not change because of the accounting role.
Upton is slated to become President and Chief Executive Officer on January 1, 2027, when Thomas J. McInerney retires, as announced October 30, 2026.
Orchestra BioMed sold 15,000,000 shares of common stock at $5.00 per share under an underwritten public offering priced November 5, 2026, and the offering closed November 9, 2026. The underwriters' 2,250,000-share option was exercised in full on November 6, 2026, and the filing puts gross proceeds at approximately $86.3 million before underwriting discounts and expenses, with the company citing the AVIM Therapy program, the BACKBEAT pivotal trial, and the Virtue SAB program as intended uses.
Offering: 15,000,000 shares at $5.00 per share, priced November 5, 2026, with Piper Sandler and TD Securities as representatives of the underwriters
Underwriters' 30-day option for 2,250,000 additional shares was exercised in full on November 6, 2026
Gross proceeds of approximately $86.3 million before underwriting discounts, commissions and other offering expenses; offering closed November 9, 2026
Stated uses: AVIM Therapy program, BACKBEAT global pivotal trial, Virtue SAB program and its coronary in-stent restenosis trial, other product candidates, and working capital
Pathward Financial's Compensation Committee approved a $340,923 cash payment to Anthony Sharett, who resigned as President effective October 23, 2026. The payment recognizes his annual incentive award for fiscal 2026, which he would not otherwise have received because of his departure. The payment depends on his signing an acknowledgement, and the company plans to file it with its 10-K if he does.
Committee approved the $340,923 payment on November 3, 2026.
Payment is tied to the fiscal year ended September 30, 2026, based on predetermined performance measures and an individual discretionary component.
Sharett stopped being employed by the company and Pathward on October 23, 2026.
Payment is subject to Sharett signing an acknowledgement; the company intends to file it with its 10-K if executed.
National Health Investors filed an 8-K on November 9, 2026, furnishing a press release titled "NHI Issues Investor Update" and a presentation titled "Q 3 2026 Business Update." The filing points to an online location for the update and includes no financial results, guidance, or other figures, so shareholders cannot assess performance changes from this filing alone.
Exhibit 99.1 is a press release titled "NHI Issues Investor Update" dated November 9, 2026.
Exhibit 99.2 is a presentation titled "Q 3 2026 Business Update" dated November 9, 2026.
The press release directs readers to the company's investor website for the update; the filing states no financial figures.
Item 7.01 information is furnished, not filed, under Section 18 of the Exchange Act.
MVB Financial Corp. entered into restated employment agreements dated November 5, 2026 with Craig B. Greathouse, Michael R. Sumbs, Michael L. Giorgio and Joseph R. Rodriguez. The agreements supersede prior contracts, update base salaries, and revise severance terms, including a lump-sum payment of 2.0 times salary plus target bonus after a termination without cause tied to a change in control. Rodriguez's title changed from Chief Risk Officer to EVP, Chief Legal Officer and Corporate Secretary.
Base salaries: $400,000 for Greathouse, $400,000 for Sumbs, $425,000 for Giorgio and $416,000 for Rodriguez.
Termination without cause, no change in control: 12 months of base salary, up to 12 months of COBRA premium coverage, and a pro-rated annual bonus.
Termination without cause tied to a change in control: lump sum of 2.0 times annualized base salary plus target annual bonus, and up to 24 months of COBRA coverage.
Rodriguez's title changed to EVP, Chief Legal Officer and Corporate Secretary.
Hims & Hers expanded its board from nine to ten directors and appointed Dr. Andrew Huberman, 51, effective immediately, as a director who is not independent under NYSE standards. The same week, the company's subsidiary agreed to pay Dr. Huberman a $3.5 million annual advisory fee and a separate company agreement pays his media company, Scicomm Media, $5 million a year, a related-party arrangement that shareholders may weigh against the board seat.
Dr. Andrew Huberman, 51, appointed to the board on November 4, 2026, filling a newly created seat; not on any committee.
Advisory Agreement dated November 5, 2026: $3,500,000 annual cash fee for two years, plus up to $1,000,000 per year for short-form videos.
Marketing Agreement with Scicomm Media LLC, co-owned by Dr. Huberman: $5,000,000 annual fee for up to three years; his interest is about $2,100,000 annually.
Director cash retainer of $50,000 and equity award valued at $250,000, prorated through the 2027 annual meeting.
ZeroStack Corp. agreed on November 3, 2026 to sell all outstanding shares of its wholly owned subsidiary Phatebo GmbH to New Horizon Pharma B.V. for an aggregate price of €2,150,000. Closing depends on German foreign direct investment clearance and other agreed closing conditions, so the sale is not yet complete. The filing does not state the effect of the sale on ZeroStack's financial results.
Buyer: New Horizon Pharma B.V.; the company owns 100% of Phatebo GmbH before the sale.
Aggregate purchase price: €2,150,000.
Closing requires German foreign direct investment clearance and other closing conditions in the Purchase Agreement.
Purchase Agreement dated November 3, 2026 is filed as Exhibit 10.1.
Texas Instruments completed the sale of $2 billion of senior notes on November 9, 2026, split into four $500 million tranches maturing in 2028, 2031, 2033 and 2036. The filing is a debt financing that adds to the company's borrowings, and it sets coupons of 5.000% to 5.750%, which shareholders may weigh against the cost of that debt.
Four $500 million tranches: 5.000% notes due 2028, 5.350% due 2031, 5.500% due 2033 and 5.750% due 2036
Sold under an underwriting agreement dated October 26, 2026 with J.P. Morgan Securities LLC, Citigroup Global Markets Inc., BofA Securities, Inc. and U.S. Bancorp Investments, Inc. as representatives
Issued under a 2011 indenture with U.S. Bank Trust Company, National Association, as trustee, and offered under a Form S-3 filed February 14, 2025
NiSource Inc. closed the sale of $600 million of 5.400% senior notes due 2032 on November 9, 2026, under an existing shelf registration. The company said it plans to use the net proceeds for general corporate purposes, including capital expenditures, working capital and repaying existing debt. This is a routine debt financing that adds to the company's borrowings but the filing does not give any effect on earnings or guidance.
Principal amount: $600 million of 5.400% Notes due 2032
Terms Agreement dated November 2, 2026; sale closed November 9, 2026
Lead underwriters: BMO Capital Markets, KeyBanc Capital Markets, Mizuho Securities USA and PNC Capital Markets
Proceeds for general corporate purposes, including capital expenditures, working capital and debt repayment
Fortune Brands Innovations elected Victor Grizzle, former CEO of Armstrong World Industries, to its Board effective January 1, 2027. Directors David Mackay and Ann Fritz Hackett have each said they will retire from the Board, and the filing describes these as planned retirements, not disagreements with the Company. The filing contains no financial results, so the change is a board composition update rather than a direct measure of business performance.
Victor Grizzle elected Class I director effective January 1, 2027; term runs to the 2027 annual meeting; appointed to Nominating and Governance and Compensation Committees
David Mackay to retire from the Board effective December 9, 2026
Ann Fritz Hackett to retire effective immediately after the 2027 annual meeting; reclassified as a Class III director effective December 9, 2026
Press release issued November 9, 2026 furnished as Exhibit 99.1
National Health Investors filed its Q3 2026 Supplemental Information as Exhibit 99.1 to a Form 8-K, furnished under Regulation FD and not deemed filed under the Exchange Act. The filing reports portfolio figures as of September 30, 2026, including $292.6 million of annualized adjusted NOI for contracts in place, but the income statement and per-share tables in the text provided are not legible enough to assess quarterly profit or guidance.
Annualized adjusted NOI of $292.6 million for contracts in place at September 30, 2026
Real Estate Investments annualized adjusted NOI of $246.5 million and annualized cash lease revenue of $226.3 million
SHOP accounts for 15.7% of the portfolio's annualized adjusted NOI
Park Dental Partners closed its acquisition of the dental services organization supporting Village Family Dental on November 6, 2026, expanding into North Carolina, its fourth state. Base consideration was approximately $39.1 million, including 474,535 restricted shares valued at about $9.2 million, with potential aggregate consideration of up to about $46.0 million including earnouts. The company said the transaction's financial impact, including on 2026 guidance, will be shared with its earnings release on November 12, 2026.
Closed November 6, 2026; the transaction was first disclosed August 10, 2026, and adds 12 practice locations and 47 doctors.
Base consideration of approximately $39.1 million, with up to $4.6 million EBITDA-based contingent consideration and up to $2.3 million employment-contingent consideration.
Credit agreement amended to raise the maximum revolving commitment from $15.0 million to $25.0 million and add the North Carolina subsidiary as a co-borrower.
Company will release earnings November 12, 2026, with a call on November 13, and will address the transaction's impact on 2026 guidance then.
Kustom Entertainment amended its Unit Purchase Agreement to acquire TFL, LLC, extending the outside termination date from October 15, 2026 to December 18, 2026. The amendment also sets expense payment and reimbursement terms for the Sellers, and the closing remains subject to third-party consents, stockholder approvals, and other customary conditions.
Outside termination date moved from October 15, 2026 to December 18, 2026
If the deal does not close by December 18, 2026, Kustom will pay the Sellers' eligible expenses incurred after November 16, 2026
If the agreement is terminated, Kustom will reimburse up to $200,000 of Sellers' costs for an incremental audit within five business days
On November 6, 2026, the Compensation and Human Capital Committee approved one-time retention stock option awards for certain executive officers, including three named executive officers: CFO Benjamin R. Wheeler, COO Mark S. Verratti, and CSO Dale Muzzey. The awards are intended to promote retention and continuity as the company executes initiatives to improve operational efficiencies and financial performance, and the options vest on the third anniversary of the grant date.
Awards approved November 6, 2026, under the 2026 Employee, Director and Consultant Equity Incentive Plan.
Exercise price equals the closing price of common stock on the grant date; options vest and become exercisable on the third anniversary, subject to continued service, and have a ten-year term.
Form of stock option agreement filed as Exhibit 10.1.
Ribbon Acquisition Corp. rescheduled its Extraordinary General Meeting of Shareholders from November 14, 2026 to November 13, 2026, with the start time unchanged at 10:00 a.m. Eastern Time. Proxies already submitted will be voted at the new date unless revoked, so shareholders who have already voted need not take further action.
Meeting moved from November 14, 2026 to November 13, 2026, at 10:00 a.m. Eastern Time
Only shareholders of record as of February 18, 2026 are entitled to vote
Previously submitted proxies will be voted at the rescheduled meeting unless revoked
On November 9, 2026, CRH America Finance, a wholly owned subsidiary of CRH plc, completed the sale of four series of U.S. dollar guaranteed notes, fully guaranteed by CRH plc, with principal amounts totaling $4.2 billion. The company said net proceeds are expected to fund tender offers for outstanding Arcosa, Inc. notes, repay existing debt and support general corporate purposes, which adds to CRH's debt obligations while refinancing and reshaping its borrowings.
Four series issued: $1.35 billion 5.375% notes due 2032, $1.0 billion 5.625% notes due 2034, $1.35 billion 5.750% notes due 2037, and $500 million 6.250% notes due 2057
Notes were sold under an underwriting agreement dated November 4, 2026, with Barclays Capital, J.P. Morgan Securities and Morgan Stanley as representatives
Net proceeds are expected to finance tender offers for Arcosa, Inc. notes, repay existing debt and fund general corporate purposes
Mueller Industries' board appointed Devin K. Denner as a director effective January 1, 2027, to fill the seat vacated when Gary S. Gladstein retires from the board on December 31, 2026. The company also declared a regular quarterly cash dividend of 17.5 cents per share, payable December 18, 2026 to shareholders of record on December 4, 2026.
Devin K. Denner appointed to the board effective January 1, 2027, replacing Gary S. Gladstein, who retires December 31, 2026
Denner's director pay: annual fee of $82,000 and new director initial equity grant with a grant-date fair value of $170,000, both prorated for the partial year
Quarterly cash dividend of 17.5 cents per share payable December 18, 2026 to holders of record on December 4, 2026
The board has determined Denner is independent under NYSE rules
Five Star Bancorp appointed Christopher Myers, former President and CEO of CVB Financial Corp., to its Board of Directors effective November 4, 2026, and designated him Vice Chairperson. He will serve on the Strategy and Asset Liability Committees, and the filing says the appointment supports the bank's Southern California expansion.
Appointment effective November 4, 2026; Myers serves on the Strategy and Asset Liability Committees
Designated Vice Chairperson; the director compensation policy sets an annual Vice Chairperson cash retainer of $29,000 and equity grant of $29,000
Myers was President and CEO of CVB Financial Corp. for nearly 15 years, retiring in 2020 when it had about $11.5 billion in assets
Filing states there are no arrangements under which Myers was selected as a director
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.